Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  General Electric Company    GE

GENERAL ELECTRIC COMPANY (GE)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

General Electric Company : Omnyx Ships Sixth VL4 Digital Pathology Scanner

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/27/2011 | 04:05pm CEST

GE announced today the shipment of the Omnyx? VL4 scanner to beta customers worldwide. To date, six Omnyx VL4 scanners have been shipped and are in operation for testing purposes. This marks a significant milestone in Omnyx's efforts to deliver a leading Integrated Digital Pathology solution. The Omnyx solution will be demonstrated at the upcoming Pathology Visions conference in San Diego.

The Omnyx VL4 scanner was created through the joint venture of UPMC and GE Healthcare. It is designed to resolve the tradeoff between speed and image quality through its patented two camera technology. All scanning operations including tissue detection and focus are automated to minimize labor. It is tightly integrated to an enterprise software solution that enables high-speed digital viewing over standard networks and provides a complete digital workflow for research use for both the pathologist and histology personnel.

George Michalopolous, Chair of Pathology at UPMC, comments, "The recent shipment of the VL4 Scanner to UPMC allows us to further test the Omnyx technology and make progress with our digitization plans for our department. Whether you look at the software system or their scanning instruments, the Omnyx team has developed an integrated product that promises to advance pathology."

Feedback from the various beta testing sites is instrumental in preparing the products for commercial availability.

Dr. Sylvia Asa, Chair of Pathology at University Health Network said, "I have been impressed with the image quality of the VL4 and I have high expectations for the Omnyx product. The Omnyx images are the best I have seen. In addition, there were several instances when I favored the Omnyx digital image on the monitor over the glass slide in the microscope."

So far, University Health Network (UHN) in Toronto Canada has scanned and reviewed over 2,000 slides as part of its testing activities. The facility started with 5 pathologists and, within 7 weeks, had 22 pathologists from nine specialty areas testing the system. This demonstrates its intuitive ease of use and is a result of the system having been designed by pathologists, for pathologists. Dr. Andrew Evans will discuss UHN's preliminary experience with the Omnyx Integrated Digital Pathology solution and the VL4 scanner at the upcoming Pathology Visions tradeshow in San Diego.

Gene Cartwright, CEO of the Omnyx joint venture comments, "We are grateful and thankful for the support we are receiving from our beta sites. Great customers help us make a better product. There is no better way of making sure we have it right than working hand-in-hand with our customers. We expect the field of digital pathology will advance very quickly once a complete solution is made available. The shipment of the Omnyx VL4 scanner is a very important milestone toward that goal."

The Omnyx Integrated Digital Pathology solution is designed to integrate into a comprehensive platform what are often stand-alone products. It combines high speed, high quality whole slide scanning with scalable information technology products to create a solution that addresses the reliability and process requirements of pathologists and enables single and multi-site organizations to benefit from increased efficiencies and greater access to peers in the field. The Omnyx products are for research use only and not for diagnostic use.

The Omnyx product line will include scanners, workstations, algorithms, servers, and digital archives for storage.

By digitizing the slides and corresponding workflow, the Omnyx solution is intended to do what a traditional microscope cannot, and improve collaboration, communication and efficiency.

ABOUT OMNYX:

Omnyx, LLC, (www.omnyx.com) is a joint venture of GE Healthcare and UPMC (the University of Pittsburgh Medical Center) with locations in Pittsburgh, Pa. and Piscataway, N.J. The company is developing an Integrated Digital Pathology system to allow pathology departments worldwide to move to an all-digital workflow. Their products include a family of high speed whole-slide scanners and an enterprise software product enabling image management, workflow automation, image analysis algorithms and system integration. Close collaboration with pathologists at UPMC and other institutions along with their relationship with GE Healthcare allows Omnyx to focus its innovation on the needs of anatomic pathologists worldwide. Omnyx products are currently in development and are for research use only. They are not for use in diagnostic procedures.

ABOUT GE HEALTHCARE:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

For our latest news, please visit http://newsroom.gehealthcare.com

GE Healthcare
Corey Miller, 414.469.5499
[email protected]
OR
Omnyx
Tony Melanson, 857.272.1321
[email protected]


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GENERAL ELECTRIC COMPANY
01:48aGENERAL ELECTRIC : Handheld ultrasound aids patient care, prehospital and in the..
PU
05/24WESTINGHOUSE AIR BRAKE TECHNOLOGIES : General Electric`s Transportation Unit to ..
AQ
05/24Jet engines help power cobalt to 10-year highs
RE
05/24GENERAL ELECTRIC : Kenya Targets African Development Bank to Back Coal Project
AQ
05/24GENERAL ELECTRIC : Akita Matsui Trading Says General Electric Shares Rise on Wab..
AQ
05/24GENERAL ELECTRIC : The GE Brief – May 24, 2018
PU
05/24GENERAL ELECTRIC : GE's Chief Warns of No Quick Fix -- WSJ
DJ
05/24GENERAL ELECTRIC : GE Chief Gives Cautious Outlook for Power Business -- 2nd Upd..
DJ
05/23GE Has Steepest One-Day Decline in Nine Years -- Data Talk
DJ
05/23GE cannot guarantee dividend, still fixing some units, CEO says
RE
More news
News from SeekingAlpha
05/24Baker Hughes General Electric Is Up Over 30% Since The February Low - Is GE G.. 
05/24GENERAL ELECTRIC : Trifecta Of Bad News 
05/24GE : The Flannery Effect 
05/24GE'S JOHN FLANNERY IS IN THE NEWS AG : Stock Price Down 7.3% 
05/24Valuation Insights On General Electric 
Financials ($)
Sales 2018 121 B
EBIT 2018 11 910 M
Net income 2018 7 227 M
Debt 2018 56 195 M
Yield 2018 3,39%
P/E ratio 2018 19,42
P/E ratio 2019 16,36
EV / Sales 2018 1,48x
EV / Sales 2019 1,44x
Capitalization 123 B
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | GE | US3696041033 | 4-Traders
Technical analysis trends GENERAL ELECTRIC COMPANY
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 17,5 $
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
John L. Flannery Chairman & Chief Executive Officer
Daniel C. Janki Treasurer & Senior VP-Global Operations
Jamie S. Miller Chief Financial Officer
Jim Fowler Chief Information Officer
Victor Abate Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
GENERAL ELECTRIC COMPANY-12.55%123 158
3M COMPANY-14.28%117 949
SIEMENS0.16%115 706
HONEYWELL INTERNATIONAL-1.87%113 025
ILLINOIS TOOL WORKS-10.26%50 157
JARDINE MATHESON HOLDINGS LIMITED6.14%47 621